Recently Featured

NIH Diversity Programs Doubled Undergraduates’ Odds of Earning a Ph.D., 20-Year Study Reveals

June 19, 2026
A recent 20-year study published in the journal Science Advances has revealed that two diversity-oriented programs supported by the National Institutes of Health (NIH) significantly increased the likelihood of undergraduate students earning a Ph.D. The findings indicate that participation in these programs doubled the odds of achieving this advanced degree, highlighting the effectiveness of targeted…

Understanding the Investigational New Drug (IND) Application Process

June 19, 2026
The Investigational New Drug (IND) application is a critical step in the drug development process, allowing sponsors to begin clinical trials in humans. This application must adhere to stringent regulations set forth by the FDA, ensuring that the proposed investigational drug is safe for initial use in clinical settings. The IND process encompasses various types,…

UniQure to File Gene Therapy for Approval, Reflecting Major Shifts at FDA

June 19, 2026
UniQure has announced its intention to file for approval of its gene therapy, a significant move that underscores evolving dynamics within the FDA. This decision comes in the wake of recent leadership changes at the agency, notably the departures of prominent figures such as Marty Makary and Vinay Prasad. Analysts suggest that the current FDA…

New Analytical Model Addresses Purification Optimization Tradeoffs

June 19, 2026
Biopharmaceutical manufacturers face a critical decision: prioritize speed or quality in two-step chromatography purification processes. While the desire for both is strong, the reality is that each choice carries inherent tradeoffs that can impact purity, stability, toxicity, processing times, and costs. A multinational research team has developed an analytical model aimed at navigating these complexities.…

Ongoing Cases